MitoCareX Pushes SLC Transporters to the Front Line of AI Drug Selection
At the intersection of cancer metabolism and inflammatory diseases, SLC transporters are moving from basic biology into drug discovery; however, this progress remains at the level of early-stage platforms and analysis, with some distance still to go before clinical evidence.